Why Screening for Celiac Disease Matters in Type 1 Diabetes—and What New Research Shows

Children with Type 1 diabetes have a higher risk of developing celiac disease, often without obvious symptoms. A long-term study offers insights into better screening approaches.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

About 1 in 9 children with Type 1 diabetes show antibody signs of celiac disease during screening, but only about half that number actually have biopsy-confirmed celiac disease.
Many children with positive celiac antibodies don't have symptoms, making screening important even when a child feels fine.
Antibody levels can go up and down over time, so repeat screening is needed rather than relying on a single test.
A higher antibody threshold may help identify children most likely to have actual celiac disease and need a biopsy.

Two Conditions That Often Travel Together

Children diagnosed with Type 1 diabetes are at greater risk of also developing celiac disease—an autoimmune condition where the body reacts to gluten. Both conditions involve the immune system mistakenly attacking the body's own cells, which may explain why they sometimes occur together.

Unlike Type 1 diabetes, which causes noticeable symptoms like increased thirst and fatigue, celiac disease can develop silently. A child may have no obvious signs, making screening an important part of Type 1 diabetes care.

What the Study Examined

Researchers in Türkiye followed 206 children newly diagnosed with Type 1 diabetes over 12 years, checking for celiac disease through blood tests. They measured an antibody called tTG-IgA, which rises when celiac disease is present. Children who tested positive underwent intestinal biopsies—the gold standard for confirming celiac disease.

Key Findings: Antibodies Alone Don't Tell the Whole Story

About 11.6% of the children tested positive for celiac antibodies at some point. However, only 4.8% actually had biopsy-confirmed celiac disease. This gap suggests that a positive antibody test doesn't always mean celiac disease is present.

Interestingly, antibody levels weren't stable. About half the children who tested positive at first became negative later. However, two-thirds of those who became negative tested positive again during follow-up. This pattern shows why doctors can't rely on a single screening test.

Finding the Right Threshold

The study used statistical analysis to identify the antibody level most likely to predict actual celiac disease. A threshold of 7.3 times the upper limit of normal appeared most useful, correctly identifying 70% of children with true celiac disease while avoiding false alarms in others.

However, the researchers noted that even at this higher threshold, some children with biopsy-confirmed celiac disease had lower antibody levels—about 8.3% of confirmed cases. This means a normal antibody test doesn't completely rule out celiac disease.

What This Means for Families

If your child has been diagnosed with Type 1 diabetes, celiac disease screening is an important part of ongoing care. Because antibody levels can fluctuate and symptoms may not be obvious, repeat screening—not just one test—provides a more complete picture.

A positive antibody result doesn't automatically mean celiac disease; further testing may be needed. Work with your diabetes care team to determine the right screening schedule and interpretation of results for your child's situation.

Evidence label

Source: Postgraduate medicine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.